Glenmark Pharma, USA continues to expand its OTC portfolio with acquisition of approved ANDAs from Wockhardt Read more
US FDA approves Bristol Myers Squibb’s CAR-T cell therapy Breyanzi for relapsed large B-cell lymphoma after one prior therapy Read more